3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
24
Neoplasm Metastasis
3
Ovarian Neoplasms
2
Prostatic Neoplasms
1
Premenopausal Breast Cancer
1
Pancreatic Neoplasms
1
Invasive Early Breast Cancer
1
First Line Metastatic Breast Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms, Male
1
Breast Cancer Metastatic
1
Interventions
pembrolizumab
1
exemestane
1
Leuprolide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Premenopausal Breast Cancer
×
exemestane
×
Clear all
NCT02990845
2023-02-22
PEER
National Taiwan University Hospital
Phase 1/2
Terminated
16 enrolled